These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


154 related items for PubMed ID: 4414485

  • 21. Effect of clindamycin and lincomycin therapy on faecal flora.
    Leigh DA, Simmons K.
    J Clin Pathol; 1978 May; 31(5):439-43. PubMed ID: 649769
    [Abstract] [Full Text] [Related]

  • 22. Clindamycin phosphate in the treatment of endometritis due to anaerobic bacteria.
    Creatsas G, Pavlatos M, Aravantinos D, Milingos S, Kaskarelis D.
    Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):203-5. PubMed ID: 7251234
    [Abstract] [Full Text] [Related]

  • 23. Erythromycin, lincomycin, and clindamycin.
    Derrick CW, Reilly KM.
    Pediatr Clin North Am; 1983 Feb; 30(1):63-9. PubMed ID: 6338470
    [No Abstract] [Full Text] [Related]

  • 24. Clindamycin and lincomycin: oral and parenteral therapy.
    JAMA; 1977 Apr 04; 237(14):1482-4. PubMed ID: 576647
    [No Abstract] [Full Text] [Related]

  • 25. The treatment of paediatric infections with the lincomycins.
    Kosmidis JC, Corbett V, Cole AJ, Finch RG, Barker JE, Geddes AM.
    Br J Clin Pract; 1973 Aug 04; 27(8):315-8. PubMed ID: 4586639
    [No Abstract] [Full Text] [Related]

  • 26. Synthesis and structure-activity relationships of novel lincomycin derivatives. Part 2. Synthesis of 7(S)-7-deoxy-7-(4-morpholinocarbonylphenylthio)lincomycin and its 3-dimensional analysis with rRNA.
    Wakiyama Y, Kumura K, Umemura E, Masaki S, Ueda K, Watanabe T, Yamamoto M, Hirai Y, Ajito K.
    J Antibiot (Tokyo); 2016 Jun 04; 69(6):428-39. PubMed ID: 26669751
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Sensitivities of clinical isolates to lincomycin and macrolide-type antibiotics (author's transl)].
    Deguchi K.
    Jpn J Antibiot; 1981 Mar 04; 34(3):419-24. PubMed ID: 7289033
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. The need for and choice of chemotherapy for anaerobic infections.
    Selkon JB.
    Scand J Infect Dis Suppl; 1981 Mar 04; 26():19-23. PubMed ID: 6941452
    [Abstract] [Full Text] [Related]

  • 31. Beware--the anaerobe bandwagon.
    Page MI.
    N Engl J Med; 1974 Feb 07; 290(6):338-40. PubMed ID: 4809286
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Changing trends in therapy of infections due to anaerobic bacteria.
    Del Bene VE.
    J S C Med Assoc; 1976 Jul 07; 72(7):260-3. PubMed ID: 1067462
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Modification of lincomycin.
    Magerlein BJ.
    Adv Appl Microbiol; 1971 Jul 07; 14():185-229. PubMed ID: 5003687
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.